Charles W. Drescher

15.5k total citations · 2 hit papers
113 papers, 11.9k citations indexed

About

Charles W. Drescher is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Charles W. Drescher has authored 113 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Reproductive Medicine, 34 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Charles W. Drescher's work include Ovarian cancer diagnosis and treatment (58 papers), Endometrial and Cervical Cancer Treatments (26 papers) and BRCA gene mutations in cancer (13 papers). Charles W. Drescher is often cited by papers focused on Ovarian cancer diagnosis and treatment (58 papers), Endometrial and Cervical Cancer Treatments (26 papers) and BRCA gene mutations in cancer (13 papers). Charles W. Drescher collaborates with scholars based in United States, South Africa and France. Charles W. Drescher's co-authors include Nicole Urban, Kathy O'Briant, Muneesh Tewari, Beatrice S. Knudsen, Rachael K. Parkin, Stacia K. Wyman, Brian R. Fritz, Patrick S. Mitchell, Evan M. Kroh and Robert Gentleman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Charles W. Drescher

110 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNAs as stable blood-based markers for cancer detection

2008 6.5k citations Patrick S. Mitchell, Rachael K. Parkin et al. Proceedings of the National Academy of Sciences profile →
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

2003 582 citations Martin McIntosh, Charles W. Drescher et al. profile →

Peers

Countries citing papers authored by Charles W. Drescher

Since Specialization

Citations

This map shows the geographic impact of Charles W. Drescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Drescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Drescher more than expected).

Fields of papers citing papers by Charles W. Drescher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Drescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Drescher. The network helps show where Charles W. Drescher may publish in the future.

Co-authorship network of co-authors of Charles W. Drescher

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Drescher. A scholar is included among the top collaborators of Charles W. Drescher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Drescher. Charles W. Drescher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sexual Orientation and Gender Identity Data Collection in Cancer Care: A Nationwide Landscape Assessment Update 2024 ·JCO Oncology Practice ·Elizabeth Cathcart-Rake, Aminah Jatoi, Emily V. Dressler, Carol Kittel, Kathryn E. Weaver, Chandylen L. Nightingale, Heather B. Neuman, Kah Poh Loh, Charles Kamen, Susan K. Parsons, Samilia Obeng‐Gyasi, Mary E. Cooley, Scott D. Ramsey, Andrew M. McDonald, (unknown), (unknown), (unknown), Charles W. Drescher, (unknown)	8
2	Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network 2024 ·JNCI Cancer Spectrum ·Jamie M Faro, Emily V. Dressler, Carol Kittel, (unknown), Shirley M. Bluethmann, Stephanie J. Sohl, Andrew M. McDonald, Kathryn E. Weaver, Chandylen L. Nightingale, Heather B. Neuman, Susan K. Parsons, Samilia Obeng‐Gyasi, Mary E. Cooley, Kian Ping Loh, Scott D. Ramsey, (unknown), (unknown), (unknown), Charles W. Drescher, (unknown)	1
3	Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study 2023 ·JCO Precision Oncology ·Eugene R. Ahn, Michael Rothe, Pam K. Mangat, Elizabeth Garrett‐Mayer, (unknown), John K. Chan, Michael L. Maitland, (unknown), (unknown), Ani Sarkis Balmanoukian, Charles W. Drescher, Rui Li, Apostolia M. Tsimberidou, Charles A. Leath, (unknown), (unknown), Susan Halabi, Richard L. Schilsky	12
4	A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses 2022 ·Clinical Cancer Research ·Ehsan Irajizad, Chae Young Han, Joseph Celestino, Ranran Wu, Eunice Murage, (unknown), Jennifer B. Dennison, Jody V. Vykoukal, James P. Long, Kim‐Anh Do, Charles W. Drescher, Karen H. Lu, Zhen Lü, Robert C. Bast, Samir Hanash, Johannes F. Fahrmann	10
5	Cancer case trends following the onset of the COVID‐19 pandemic: A community‐based observational study with extended follow‐up 2021 ·Cancer ·Charles W. Drescher, Adam J. Bograd, Shu‐Ching Chang, Roshanthi Weerasinghe, (unknown), R. Bryan Bell	19
6	Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer 2019 ·Cancer Immunology Research ·Kristin G. Anderson, Valentin Voillet, Breanna M. Bates, Edison Y. Chiu, (unknown), (unknown), Shannon K. Oda, Christopher B. Morse, Ingunn M. Stromnes, Charles W. Drescher, Raphaël Gottardo, Philip D. Greenberg	27
7	Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models 2019 ·Cancer Research ·Chang Li, (unknown), Iain A. McNeish, Charles W. Drescher, Paul N. Valdmanis, André Lieber	16
8	Ultrasound Molecular Imaging in a Human CD276 Expression–Modulated Murine Ovarian Cancer Model 2014 ·Clinical Cancer Research ·A.M. Lutz, Sunitha V. Bachawal, Charles W. Drescher, Marybeth A. Pysz, Jürgen K. Willmann, Sanjiv S. Gambhir	39
9	Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer 2013 ·The Journal of Alternative and Complementary Medicine ·M. Robyn Andersen, Erin Sweet, Kimberly A. Lowe, Leanna J. Standish, Charles W. Drescher, Barbara A. Goff	27
10	Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening 2012 ·Cancer Prevention Research ·Charles W. Drescher, Sarah Hawley, Jason D. Thorpe, Simone Marticke, Martin McIntosh, Sanjiv S. Gambhir, Nicole Urban	19
11	Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs 2012 ·Clinical Cancer Research ·Ines Beyer, Hua Cao, Jonas Persson, (unknown), (unknown), Qinghua Feng, Roma Yumul, Ruan van Rensburg, Zongyi Li, Ronald Berenson, Darrick Carter, Steve R. Roffler, Charles W. Drescher, André Lieber	53
12	Potentially Dangerous Complementary and Alternative Medicine (CAM) Use by Ovarian Cancer Patients 2012 ·Journal of Gynecologic Surgery ·M. Robyn Andersen, Erin Sweet, Kimberly A. Lowe, Leanna J. Standish, Charles W. Drescher, Barbara A. Goff	4
13	ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma 2011 ·PLoS Biology ·Julia Salzman, Robert J. Marinelli, Peter L. Wang, (unknown), Julie S. Nielsen, Brad H. Nelson, Charles W. Drescher, Patrick O. Brown	41
14	Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses 2009 ·Cancer Research ·Robert Strauss, Pavel Sova, Ying Liu, (unknown), Sebastian Tuve, David K. Pritchard, Paul T. Brinkkoetter, T. Möller, Oliver Wildner, Sari Pesonen, Akseli Hemminki, Nicole Urban, Charles W. Drescher, André Lieber	57
15	Circulating microRNAs as stable blood-based markers for cancer detection breakdown → 2008 ·Proceedings of the National Academy of Sciences ·Patrick S. Mitchell, Rachael K. Parkin, Evan M. Kroh, Brian R. Fritz, Stacia K. Wyman, Era L. Pogosova‐Agadjanyan, Amelia C. Peterson, Jennifer Noteboom, Kathy O'Briant, April N. Allen, Daniel W. Lin, Nicole Urban, Charles W. Drescher, Beatrice S. Knudsen, Derek L. Stirewalt, Robert Gentleman, Robert L. Vessella, Peter S. Nelson, Daniel Martin, Muneesh Tewari	6512
16	Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer 2006 ·Journal of Clinical Oncology ·Vivian Goodell, Lupe G. Salazar, Nicole Urban, Charles W. Drescher, Heidi J. Gray, Ron E. Swensen, Martin McIntosh, Mary L. Disis	113
17	Development of an ovarian cancer symptom index 2006 ·Cancer ·Barbara A. Goff, Lynn S. Mandel, Charles W. Drescher, Nicole Urban, (unknown), (unknown), Joshua Patras, B S Mahony, M. Robyn Andersen	258
18	Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancer☆ 2003 ·Gynecologic Oncology ·John V. Brown, William A. Peters, Mark A. Rettenmaier, (unknown), Michael Smith, Charles W. Drescher, John P. Micha	31
19	Metastatic Placental Site Trophoblastic Tumor: Long-Term Remission in a Patient Treated with EMA/CO Chemotherapy 1998 ·Gynecologic Oncology ·Elizabeth M. Swisher, Charles W. Drescher	38
20	The incidence of urogenital Chlamydia trachomatis infections among patients in Kumasi, Ghana 1988 ·International Journal of Gynecology & Obstetrics ·Charles W. Drescher, Thomas E. Elkins, (unknown), (unknown), (unknown), Rosalind Foster, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact